Cite
APA Citation
Bernardi, M., Carrabba, M., Messina, C., Milani, R., Sala, E., Pavesi, F., Gentner, B., Peccatori, J., Assanelli, A., Marktel, S., Corti, C., Forcina, A., Vago, L., & Ciceri, F. (n.d.). elderly patients > 65 years of age with acute myeloid leukemia and normal karyotype benefit from intensive therapeutic programs. American journal of hematology, 91(6), E302–E303. http://access.bl.uk/ark:/81055/vdc_100032419486.0x00005f